ArticleInternational journal of breast cancer2026

Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region: A Retrospective Study (TREASURE Study).

Emad Dawoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.